Prescient Therapeutics Investor Briefing – 17 March
Prescient Therapeutics (ASX: PTX) is focused on developing novel, personalised therapies for a range of cancers. Prescient’s universal
Prescient Therapeutics (ASX: PTX) is focused on developing novel, personalised therapies for a range of cancers. Prescient’s universal
Australian clinical stage biotech company Prescient Therapeutics (ASX: PTX) will undertake three internal development programs to advance its
Following more than a decade of treatments, cancer survivor Laurie Adami now plans to tackle the world’s tallest
Amid the tragedy of 2020’s global COVID-19 pandemic, it’s easy to forget the horrors inflicted on hundreds of
Laurie Adami has had a long and intricate journey with blood cancer, after being diagnosed with Non-Hodgkin Lymphoma
Cancer is a word we all dread to hear yet a cure for the deadly disease has always
ASX listed biotech company Prescient Therapeutics (ASX: PTX) has this week unveiled two significant licence agreements that forms
It is impossible to overstate the unprecedented disruptions the world is facing with COVID-19. Stock markets have plunged